Abatement Case Study
Radioxenon emissions from industrial sources such as fission based medical isotope production (MIP) facilities and nuclear reactors are generally known to be well below levels of public health and safety concern. However, the global background of radioxenon produced by MIP interferes with nuclear explosion monitoring by the International Monitoring System (IMS) developed for the Comprehensive Nuclear-Test-Ban Treaty (CTBT) (CTBTO, 2024). It was calculated that xenon emissions levels of 5×10 9 Bq/day 133 Xe were low enough to have minimal impact on International Monitoring System (IMS) stations (Bowyer et al, 2013). There are several technologies currently used to abate radioactive xenon emissions to meet regulatory release levels, and some alternative methods have been investigated to reduce xenon release levels well below required regulatory levels (Doll et al, 2014, Gueibe, et al, 2014). While MIP producers are sympathetic to the issue of radioxenon interference with IMS monitoring, the cost to implement and maintain additional abatement systems has resulted in limited implementation. Therefore, more cost-effective options for xenon abatement are needed to help reduce the impact of these emissions on nuclear explosion monitoring.